Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBG for prevention of severe oral mucositis in head and neck cancer patients undergoing radiotherapy
2008-005565-54Phase 3Completed
- Sponsor
- Biotec Pharmacon ASA
- Start
- Nov 2008
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stomatitis comparing SBG with Placebo (2 arms). Primary endpoint: Incidence of severe oral mucositis. Started Nov 2008; status: completed.
02
Drugs
Imprime PGG
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2008-005565-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005565-54.